CIT Safety & Health Research Lab has acquired the assets of LAB Research Inc.
Avril 2011 — CIT Safety & Health Research Laboratories (CIT) has acquired all the assets of LAB Research Inc.
CIT is part of the holding company Applied Biology Company (ABC). Through this acquisition, the newly created CIT-LAB group becomes one of the top five preclinical CROs. CIT is an established player in the field of preclinical contract research with more than forty years of experience.
LAB Research is a Canadian global non-clinical contract research organization that provides contract research services to the pharmaceutical, biotechnology, agro-chemical, petrochemical and industrial markets. LAB Research supports the development of its customers' products from three state-of-the-art facilities located in Canada, Denmark and Hungary.
Notre rôle dans la transaction
Oaklins' team in Canada advised the buyer in this transaction.
Contacter l'équipe de la transaction
Transactions connexes
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
En apprendre plusMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
En apprendre plusQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
En apprendre plus